Clinical Trial

LIA vs. LIA + ACB-iPACK Block for Total Knee Arthroplasty

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
LIA is the mainstay of postoperative analgesia in patients having knee arthroplasty. The combination of ACB-iPACK blocks has also been proposed as an effective analgesic modality for total knee arthroplasty. However, whether combining these two modalities yields any important incremental analgesic benefit remains unclear. The investigators hypothesized that the addition of ACB and iPACK blocks to LIA will yield clinically important analgesic benefits compared to LIA alone in patients having total knee arthroplasty.
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2021-03-18; most recent amendment 2025-07-14.
Trial Details
NCT Number NCT04808947
Lead Sponsor Women's College Hospital
Conditions Nerve Block, Neuromuscular Blockade
Enrollment 60 participants
Start Date 2027-01
Primary Completion 2027-12 (estimated)
Study Completion 2028-12 (estimated)
Updated on ClinicalTrials.gov 2025-07-16